Kestra Medical Technologies, Ltd. (KMTS)
Kestra Medical Technologies, Ltd. operates in the Medical - Instruments & Supplies industry of the Healthcare sector, headquartered in Kirkland, WA, US. The stock last traded at $27.89, down 0.04% on the session, giving a market capitalisation of $1.63B. On trailing twelve-month figures it carries a trailing P/E of -11.52, a net margin of -138.4%. Its beta of 0.58 implies it has historically moved less than the broad market.
Kestra Medical Technologies, Ltd. operates at the intersection of wearable medical technology and digital healthcare. Its core mission is to revolutionize patient outcomes in cardiovascular disease through intelligent, intuitive, and connected monitoring and therapeutic intervention solutions. The company's flagship offering is the Cardiac Recovery System (CRS) platform, which it develops and commercializes. This unified solution seamlessly integrates cardiac monitoring, therapeutic treatment, digital health capabilities, and patient support services. A central component of the CRS is the ASSURE WCD, a wearable cardioverter defibrillator specifically engineered to protect individuals at elevated risk of sudden cardiac arrest (SCA). Beyond its hardware, the CRS platform also encompasses a suite of integrated digital solutions and services. These are designed to foster enhanced engagement and oversight between patients and healthcare providers, ultimately striving for improved patient well-being. Founded in 2014, the company is headquartered in Kirkland, Washington.
Kestra Medical Technologies, Ltd. is most often compared with the following Healthcare names: